Okamoto M, Toyama M, Baba M. The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020 Jul 30:104902. doi: 10.1016/j.antiviral.2020.104902.
PMID: 32739404